Thiophene derivatives useful as ocular hypotensive agents

Details for Australian Patent Application No. 2009239371 (hide)

Owner Allergan, Inc.

Inventors Ngo, Vinh X.; Old, David W.

Agent Davies Collison Cave

Pub. Number AU-A-2009239371

PCT Pub. Number WO2009/132087

Priority 61/047,726 24.04.08 US

Filing date 22 April 2009

Wipo publication date 29 October 2009

International Classifications

C07D 233/40 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

A61K 31/381 (2006.01) - having five-membered rings

A61P 27/02 (2006.01) Drugs for disorders of the senses

Event Publications

18 November 2010 PCT application entered the National Phase

  PCT publication WO2009/132087 Priority application(s): WO2009/132087

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009239372-Substituted gamma lactams as therapeutic agents

2009239369-Substituted arylcyclopentenes as prostaglandin EP2 agonists